PRA International
Suite 400
Raleigh, NC 27612
PRA International Expands Electronic Publishing Capability to Support Regulatory Submissions
RESTON, Va., June 18 - PRA International, a leading clinical research organization, today announced that its Regulatory Affairs group now offers a fully compliant technology option for sponsors to file electronic common technical documents (eCTD) with regulatory agencies. The move is in preparation for the U.S. Food and Drug Administration's plan to require all electronic submissions to be in...
Read More »PRA International Enters Into Merger Agreement With Genstar Capital
PRA Stockholders to Receive $30.50 Per Share in Cash; Transaction Valued at $790 Million RESTON, Va., July 25 / -- PRA International (NASDAQ:PRAI), a leading global clinical research organization, today announced that it has entered into a definitive merger agreement to be acquired by affiliates of Genstar Capital, LLC ( Genstar ), a private equity firm and a beneficial owner of 12.8% of the...
Read More »PRA International Expands Electronic Publishing Capability to Support Regulatory Submissions
RESTON, Va., June 18 - PRA International, a leading clinical research organization, today announced that its Regulatory Affairs group now offers a fully compliant technology option for sponsors to file electronic common technical documents (eCTD) with regulatory agencies. The move is in preparation for the U.S. Food and Drug Administration's plan to require all electronic submissions to be in...
Read More »PRA International to Present Audioconference on Clinical Development in Asia February 8
PRA's Director of Operations - Asia to Speak RESTON, Va., Jan. 16-- PRA International (NASDAQ:PRAI), a leading clinical research organization, today announced that Edward Ian, the company's Director of Operations - Asia, will present a one- hour audioconference on conducting clinical research in the region on Thursday, February 8, 2007 at 11:30 a.m. EST. In Clinical Investigations in Asia-Local...
Read More »